Search NLS News

The Board of Directors of Oasmia has resolved on a new issue of shares with preferential rights for existing shareholders of approximately SEK 151 million. The purpose of the Rights Issue is to finance the continued development of the company and its projects in accordance with its business plan and strategy, it states. Shareholders in […]

The innovation programme SPARK Denmark will also help to strengthen Denmark’s talent pipeline and provides a major career boost for individual researchers and innovators. SPARK Denmark is being established at Denmark’s five largest universities based on a grant of 44 million DKK from the Novo Nordisk Foundation. SPARK aims to improve the translation of promising […]

Kristin Wannerberger’s career path has taken her from Sweden, to Denmark and now, Switzerland, where she is Director R&D Alliance Management at Ferring. As Head of R&D Alliance Management at Ferring Pharmaceuticals, Kristin Wannerberger is today directing several alliances, including the up-and-coming field of human microbiota/microbiome. The human microbiome is the collection of microbial genomes […]

AstraZeneca and Daiichi Sankyo have received notification of acceptance of the supplemental Biologics License Application (sBLA) of Enhertu for the treatment of adult patients in the US with unresectable or metastatic HER2-positive breast cancer who have received a prior anti-HER2-based regimen. The application has also been granted Priority Review. The sBLA is being reviewed under […]

Targovax has announced that patents no CN108495934 and JP6974350 have been granted by the Chinese and Japanese Patent Offices, respectively. The patents cover the use of ONCOS-102 in combination with chemotherapy in malignant mesothelioma. “We are delighted that these patents have been granted, further strengthening Targovax’s intellectual property portfolio. The 30-month data from our ONCOS-102 […]

Observe Medical and the shareholders of Biim Ultrasound have announced a definitive agreement whereby Observe Medical will acquire 100% of the shares in Biim Ultrasound. The transaction, which values Biim Ultrasound at approximately NOK 185 million (EUR 18.5 million), will be settled in cash and shares. The agreement further strengthens Observe Medical’s position as a […]

An international metastudy led by researchers at Karolinska Institutet has identified a specific gene variant that protects against severe COVID-19 infection. The researchers managed to pinpoint the variant by studying people of different ancestries, a feat they say highlights the importance of conducting clinical trials that include people of diverse descents. The results are published […]

AstraZeneca has signed a collaboration agreement with Scorpion Therapeutics to discover, develop and commercialize precision medicines against previously hard-to-target cancer proteins, with the potential to transform oncology treatment. “Unlocking potentially transformative biology is pivotal for delivering the next wave of cancer treatments. Scorpion’s innovative platform is a strong strategic fit as we explore a range […]

The Board of Directors of Dignitana AB has appointed Magnus Blixt as the new CEO of Dignitana. He will assume CEO responsibilities after the Annual General Meeting on 25 May 2022.  At that time current CEO William Cronin will transition to serve as Deputy Chairman of the Board of Directors and will be a Senior Advisor […]

Lokon Pharma has announced a collaboration with Affibody to combine oncolytic viruses with Affibody molecules. “Lokon’s oncolytic adenovirus platform encodes human immunostimulatory genes to induce anti-tumor immunity in cancer patients. We already have one virus in clinical development, LOAd703, and we are expanding our pipeline to meet the demand of different types of malignancies” says […]